Blue Abundance Biochemistry: Net loss of 191 million yuan in 2025.

Blue Rich Biochemicals announced that its operating income in 2025 was 2.342 billion yuan, a year-on-year increase of 30.61%. The net loss attributable to shareholders of the listed company was 191 million yuan, compared to a net loss of 2.53 billion yuan in the same period last year. The company plans not to distribute cash dividends, bonus shares, or increase capital through capital reserve.